259 related articles for article (PubMed ID: 19363280)
1. Montelukast for treatment of refractory pruritus in patients on hemodialysis.
Nasrollahi AR; Miladipour A; Ghanei E; Yavari P; Haghverdi F
Iran J Kidney Dis; 2007 Oct; 1(2):73-7. PubMed ID: 19363280
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
3. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: a prospective, double-blind, randomized, placebo-controlled study.
Fujiwara H; Konno R; Netsu S; Odagiri K; Taneichi A; Takamizawa S; Ohwada M; Suzuki M
Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):195-8. PubMed ID: 19944517
[TBL] [Abstract][Full Text] [Related]
5. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.
Lehtimäki L; Petäys T; Haahtela T
Int Arch Allergy Immunol; 2009; 149(2):150-3. PubMed ID: 19127072
[TBL] [Abstract][Full Text] [Related]
6. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.
Harel Z; Riggs S; Vaz R; Flanagan P; Harel D
J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):183-6. PubMed ID: 15125904
[TBL] [Abstract][Full Text] [Related]
7. Pilot study on recurrent aphthous stomatitis (RAS): a randomized placebo-controlled trial for the comparative therapeutic effects of systemic prednisone and systemic montelukast in subjects unresponsive to topical therapy.
Femiano F; Buonaiuto C; Gombos F; Lanza A; Cirillo N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):402-7. PubMed ID: 19926502
[TBL] [Abstract][Full Text] [Related]
8. Low-dose doxepin for treatment of pruritus in patients on hemodialysis.
Pour-Reza-Gholi F; Nasrollahi A; Firouzan A; Nasli Esfahani E; Farrokhi F
Iran J Kidney Dis; 2007 Jul; 1(1):34-7. PubMed ID: 19357442
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
Sanada S; Tanaka T; Kameyoshi Y; Hide M
Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
[TBL] [Abstract][Full Text] [Related]
10. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
Veien NK; Busch-Sørensen M; Stausbøl-Grøn B
J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Effect of Montelukast for Treatment of Uremic Pruritus in Hemodialysis Patients.
Mahmudpour M; Roozbeh J; Raiss Jalali GA; Pakfetrat M; Ezzat Zadegan S; Sagheb MM
Iran J Kidney Dis; 2017 Jan; 11(1):50-55. PubMed ID: 28174353
[TBL] [Abstract][Full Text] [Related]
12. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
13. The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis.
Bouchelouche K; Nordling J; Hald T; Bouchelouche P
J Urol; 2001 Nov; 166(5):1734-7. PubMed ID: 11586212
[TBL] [Abstract][Full Text] [Related]
14. A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients.
Young TA; Patel TS; Camacho F; Clark A; Freedman BI; Kaur M; Fountain J; Williams LL; Yosipovitch G; Fleischer AB
J Dermatolog Treat; 2009; 20(2):76-81. PubMed ID: 18821119
[TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans.
Cartmell MT; O'Reilly DA; Porter C; Kingsnorth AN
J Hepatobiliary Pancreat Surg; 2004; 11(4):255-9. PubMed ID: 15368110
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized, placebo-controlled, double-blind study of montelukast's effect on persistent middle ear effusion.
Schoem SR; Willard A; Combs JT
Ear Nose Throat J; 2010 Sep; 89(9):434-7. PubMed ID: 20859868
[TBL] [Abstract][Full Text] [Related]
17. Improvement in vulvar vestibulitis with montelukast.
Kamdar N; Fisher L; MacNeill C
J Reprod Med; 2007 Oct; 52(10):912-6. PubMed ID: 17977165
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pruritus with topically applied opiate receptor antagonist.
Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus.
Chen YC; Chiu WT; Wu MS
Am J Kidney Dis; 2006 Jul; 48(1):69-76. PubMed ID: 16797388
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis.
Bisgaard H;
Am J Respir Crit Care Med; 2003 Feb; 167(3):379-83. PubMed ID: 12406832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]